comparemela.com

Latest Breaking News On - Irepemat - Page 1 : comparemela.com

IRLAB Therapeutics: IRLAB Obtains Regulatory Approval to Conduct Phase IIb Study With Pirepemat - One Step Closer To Improving Balance and Reducing Fall Injuries For People Living With Parkinson s Disease

GOTHENBURG, SWEDEN / ACCESSWIRE / December 22, 2021 / IRLAB Therapeutics (STO:IRLAB-A) (FRA:6IRA)IRLAB (Nasdaq Stockholm: IRLAB A) IRLAB receives regulatory approval from the Swedish MPA for conducting

Vastra gotalands lanViktor siewertzJoakim tedroffClinical research organizationIr corporate communicationsNasdaq stockholmVoluntary harmonization procedureNicholas watersIntegrative screening processNasdaq stockholm main

vimarsana © 2020. All Rights Reserved.